News

News
Partner news

VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen

Read full story
Partner news

Bioasis Enters Into Research Collaboration With Janssen

Read full story
Partner news

Remix Therapeutics Enters Collaboration with Janssen to Advance Small Molecule Therapeutics Using REMaster Drug Discovery Platform to Modulate RNA Processing

Read full story
Partner news

VerImmune Inc Announces Research Collaboration with Janssen to Leverage its Unique Immuno-oncology Therapeutic Platform

Read full story
Partner news

Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance Novel Antibody-Drug Conjugates

Read full story
Partner news

Navitor Pharmaceuticals Announces Janssen Has Acquired Anakuria Therapeutics, Inc.

Read full story
Partner news

Leyden Labs Licenses Pan-Influenza Antibody from Janssen

Read full story
Partner news

The UK’s largest ever health research programme to transform the prevention, detection and treatment of diseases

Read full story
Partner news

TRexBio Announces Collaboration with Janssen to Discover Novel Targets for Immunology and Inflammation

Read full story
Partner news

i2O Therapeutics Announces Research Collaboration and Option Agreement with Janssen to Investigate the Oral Delivery of Macromolecules

Read full story
Partner news

SRI International announces collaboration agreement with Janssen

Read full story
Partner news

Genocea Biosciences Provides Corporate Update

Read full story
Partner news

Dyadic Announces Research, License and Collaboration Agreement with Janssen for the Manufacture of Therapeutic Protein Candidates using its C1 Platform

Read full story
Partner news

Philogen announces new collaboration with Janssen to discover small molecule therapeutics

Read full story
Partner news

Ultromics Announces Collaboration with Janssen to Develop AI for Patients with Amyloidosis with Cardiac Involvement

Read full story